Karl Ludwig Rost

Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva

Uwe Fuhr, Karl Ludwig Rost · Pharmacogenetics · 1994 · 182 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Increase of cytochrome P450IA2 activity by omeprazole: Evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin

Karl Ludwig Rost, H. Brösicke, Jürgen Brockmöller et al. · Clinical Pharmacology & Therapeutics · 1992 · 134 citations

Medicine, Pharmacokinetics, Pharmacology +16

Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations

Uwe Fuhr, Karl Ludwig Rost, R. Engelhardt et al. · Pharmacogenetics · 1996 · 130 citations

Medicine, Pharmacokinetics, Pharmacology +17

Safety of Hydroxocobalamin in Healthy Volunteers in a Randomized, Placebo-Controlled Study

Wolfgang Uhl, Arno Nolting, Georg Golor et al. · Clinical Toxicology · 2006 · 112 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: Coincidence with plasma clearance and breath test

Karl Ludwig Rost, Ivar Roots · Clinical Pharmacology & Therapeutics · 1994 · 104 citations

Medicine, Pharmacokinetics, Pharmacology +17